Please login to the form below

Not currently logged in
Email:
Password:

women's health

This page shows the latest women's health news and features for those working in and with pharma, biotech and healthcare.

Big Pharma, Little Pharma

Big Pharma, Little Pharma

The company took a big risk when it bought Allergan’s dermatology portfolio. ... to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and

Latest news

  • Teva wins FDA OK for crucial migraine drug Teva wins FDA OK for crucial migraine drug

    Since Schultz took the helm last year, Teva has been shedding staff and restructuring the business to cut costs, selling off its women’s health business for almost $2.5bn in ... order to pay down a very high level of debt stemming from its $39bn

  • FDA rejects Allergan’s uterine fibroid drug over safety concerns FDA rejects Allergan’s uterine fibroid drug over safety concerns

    The new measurements include contraindication in women with known liver problems, liver tests before, during and after treatment and liver monitoring literature. ... The news isn’t great for Allergan, which has said it sees Esmya as a flagship brand

  • VC raises new €270m fund for European biotechs VC raises new €270m fund for European biotechs

    It currently has around 25 companies in its portfolio, including Dutch gene therapy specialist UniQure, UK women’s health start-up KaNDy Therapeutics and US biotech Argos Therapeutics which as an ... Ernst &Young predicted earlier this year that

  • 'Femtech' poised to explode, with applications set to trigger healthcare disruption 'Femtech' poised to explode, with applications set to trigger healthcare disruption

    Will be driven by strong funding and positive regulatory environment. The market for digital applications for women’s health and wellbeing is set for ‘explosive growth’, driven by almost $1 billion ... Such femtech applications target reproductive,

  • MHRA suspends new prescriptions of fibroid drug Esmya MHRA suspends new prescriptions of fibroid drug Esmya

    In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after four cases of serious liver injury - ... Allergan has said that it sees Esmya as a

More from news
Approximately 5 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    acquisition. In a third, widely reported rumour, Pfizer is said to be looking at divesting its women’s health division, which includes the product Premarin for the menopause. ... Given that Teva divested its women’s health division for $1.38B earlier

  • Advancing women in healthcare Advancing women in healthcare

    This theme was picked up in the HBA’s meeting in London, with a roundtable of women healthcare leaders hosted at Syneos Health by the President of Syneos Health Communications Europe, ... Dr Priya Agrawal is Business Unit Director, Vaccines &Women’s

  • If you’re going global, go local and go early If you’re going global, go local and go early

    Similarly, the inspiration for a recent global women’s cancer campaign originated from work with colleagues based in the Middle East - an area that might be considered an unconventional source for ... strategic and creative insights on women’s health

  • Pharma deals continue to slide Pharma deals continue to slide

    Novartis has announced a price of $475, 000 per treatment following discussion with health assessment authorities. ... The business has not performed because of generic price pressures so Teva has reduced its dividend, is laying off 7, 000 staff and is

  • Deal Watch March 2017 Deal Watch March 2017

    Duchesnay, the Canadian women’s health company, has acquired from Shionogi the rights to market Osphena, another oral treatment for dyspareunia, in North America. ... And that’s the news from the Deal Watch team, where the women are strong, the men

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

  • Topas Therapeutics appoints chief development officer and chief medical officer Topas Therapeutics appoints chief development officer and chief medical officer

    Forging a 20-year-career spanning clinical development, regulatory and medical affairs and pharmacovigilance business, Dr Sandbrink’s expertise saw him most recently at Forward Pharma, where he served as executive ... Prior to that, he held several

  • Anish Mehta appointed CEO of new women's health business Anish Mehta appointed CEO of new women's health business

    London-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the international women’s health assets portfolio it acquired from Teva Pharmaceuticals last month. ... The combination of high quality products

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    He was also chairman of GSK’s global R&D organisation for eight years and led the global integration of Novartis’ vaccine unit into GSK. ... Additionally, Dr Frank Verwiel (pictured left). joins the group’s board of directors after serving ObsEva SA

  • Clark Health Communications expands team Clark Health Communications expands team

    director in a role that will see her lead teams responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business. ... Campbell will support and assist the team across its women’s health,

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    Agus has previously held various leading positions at several pharmaceutical companies includingAbbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology. ... With experience in medical strategy,

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

  • Porterhouse Medical Group adds to its growing team of scientific and medical experts

    Claire also has plenty of experience managing digital projects and events across a range of therapy areas, including women’s health, diabetes, haematology, oncology, urology, dermatology and asthma.

  • Shionogi Ltd. appoints Star for UK launch

    sales resource to facilitate the launch of a women’s health product in the UK. ... Founded in Osaka in 1878, Shionogi’s entrepreneurial spirit and corporate philosophy of “supplying the best possible medicine to protect the health and wellbeing of

  • Star announce PharmaDoctor partnership

    Already the UK’s leading provider of pharmacy-based clinical service support packages, PharmaDoctor has recently broadened and strengthened their Medical, Commercial and Digital team capability to accelerate the expansion of ... in-pharmacy Clinics,

  • IGNIFI

    cardiovascular disease . diabetes. women’s health . nutrition . allergy . infectious diseases . wound care . ... What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda?

  • Lighthouse Medical Communications US bolster their senior scientific team

    He has blended academic and research insights with extensive experience gained from working as a senior-level strategic medical leader and advisor in medical and health communications agencies, leading teams in ... number of key therapeutic areas such

More from PMHub
Approximately 3 fully matching, plus 28 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics